Virtus ETF Advisers’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-3,609
| Closed | -$161K | – | 400 |
|
|
2021
Q3 | $161K | Sell |
3,609
-189
| -5% | -$8.43K | 0.07% | 324 |
|
|
2021
Q2 | $207K | Buy |
3,798
+1,221
| +47% | +$66.5K | 0.09% | 324 |
|
|
2021
Q1 | $193K | Buy |
2,577
+45
| +2% | +$3.37K | 0.08% | 331 |
|
|
2020
Q4 | $275K | Sell |
2,532
-952
| -27% | -$103K | 0.11% | 264 |
|
|
2020
Q3 | $308K | Sell |
3,484
-474
| -12% | -$41.9K | 0.16% | 216 |
|
|
2020
Q2 | $422K | Buy |
+3,958
| New | +$422K | 0.2% | 180 |
|
|
2018
Q4 | – | Sell |
-3,560
| Closed | -$424K | – | 391 |
|
|
2018
Q3 | $424K | Sell |
3,560
-2,612
| -42% | -$311K | 0.04% | 150 |
|
|
2018
Q2 | $630K | Buy |
+6,172
| New | +$630K | 0.56% | 127 |
|